Recommendations
|
Cleveland Research said… Cleveland Research said in a note prior to the open that its checks indicate Wendy's Q2 U.S. comps are likely trailing consensus due to "underwhelming" promotions, competition and slow progress on its breakfast efforts. ShowHide Related Items >><< - 05/24/22
- Wendy's board to 'carefully review any proposal submitted by Trian Partners'
- 05/24/22
- Wendy's up 15% to $18.70 following Trian 13D/A filing on potential transaction
- 05/24/22
- Wendy's shareholder Trian to explore potential transaction
- 05/14/22
- Trian exits Comcast position, increases stake in Invesco
- 05/25/22 MKM Partners
- Wendy's may see more 'value unlocks' from strategic options, says MKM Partners
- 05/25/22 Wedbush
- Wedbush remains bullish on Wendy's, not surprised by Trian news
- 05/25/22 Stifel
- Wendy's deal in 'low-$20 range' would be 'feasible,' says Stifel
- 05/12/22 Truist
- Wendy's price target lowered to $27 from $29 at Truist
- 05/26/22
- Wendy's affirms FY22 EPS view at 82c-86c, consensus 83c, postpones Investor Day
- 05/11/22
- Wendy's backs FY22 adjusted EPS view 82c-86c, consensus 87c
- 05/11/22
- Wendy's reports Q1 adjusted EPS 17c, consensus 18c
- 05/10/22
- Notable companies reporting before tomorrow's open
- 03/19/22
- Wendy's stock looking like a buy, Barron's says
- 05/27/22
- What You Missed On Wall Street On Friday
- 05/27/22
- What You Missed On Wall Street This Morning
- 05/25/22
- What You Missed On Wall Street On Wednesday
- 05/25/22
- What You Missed On Wall Street This Morning
- 05/26/22
- Wendy's call volume above normal and directionally bullish
- 05/26/22
- Unusually active option classes on open May 26th
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - $159.88 /
+17.55 (+12.33%) - 05/02/22
- Zscaler appoints Castle as Chief People Officer
- 04/13/22
- Synchronoss appoints Stanley Lowe as chief information security officer
- 12/22/21
- Zscaler officer Rajic sells $7.9M in company shares
- 12/20/21
- Zscaler CFO sells $4.47M in common stock
- 05/24/22
- Wendy's board to 'carefully review any proposal submitted by Trian Partners'
- 05/24/22
- Wendy's up 15% to $18.70 following Trian 13D/A filing on potential transaction
- 05/24/22
- Wendy's shareholder Trian to explore potential transaction
- 05/14/22
- Trian exits Comcast position, increases stake in Invesco
- 05/26/22
- Workday drops 7% to $155.50 after Q1 EPS misses estimates
- 05/16/22
- Lone Pine adds TSMC in Q1, exits KE Holdings and Adobe
- 02/28/22
- Workday sees FY23 subscription revenue at $5.53B-$5.55B, up 22% y/y
- 02/14/22
- Lone Pine takes stakes in Mastercard, Visa, exits Twitter, Meta Platforms
- 05/16/22
- Soros Capital buys Suncor and Mosaic during Q1, exits Alphabet
- 05/12/22
- UnitedHealth selected by State of Missouri to serve Medicaid beneficiaries
- 04/26/22
- Change says UnitedHealth to sell ClaimsXten for $2.2B if deal closes
- $425.30 /
+47.685 (+12.63%) - 05/26/22
- Ulta Beauty jumps 7.6% to $406.50 after Q1 earnings beat and guidance raise
- 05/19/22
- Ulta Beauty launches retail media network UB Media
- 03/28/22
- PayPal broadens access to post purchase services for merchants
- 03/11/22
- Ulta Beauty approves new $2B share repurchase authorization
- 05/27/22
- Twitter board does not accept resignation of Silver Lake's Egon Durban
- 05/25/22
- Twitter up 9% after Elon Musk files amended 13D related to takeover agreement
- 05/25/22
- Musk commits to provide additional $6.25B in equity financing for Twitter deal
- 05/20/22
- Elon Musk: We will never surrender/settle an unjust case against us
- $759.79 /
+52.67 (+7.45%) - 05/24/22
- Cathie Wood's ARK Investment bought 26.1K shares of Tesla today
- 05/23/22
- Cathie Wood's ARK Investment bought 15.9K shares of Tesla today
- 05/20/22
- Musk denies he sexually harassed flight attendant on private jet
- 05/10/22
- SoFi Technologies off lows after resumption, remains down 13%
- 05/10/22
- SoFi Technologies trading resumes
- 05/10/22
- SoFi Technologies to resume trading at 2:10 pm ET
- 05/10/22
- SoFi Technologies CEO says 'off to a great start' standing up bank
- 03/24/22
- Sallie Mae appoints William Wolf as CPO
- 01/26/22
- Sallie Mae board approves new $1.25B share repurchase program
- 01/26/22
- Sallie Mae to acquire Nitro College, terms not disclosed
- 05/19/22
- Siga Technologies receives FDA approval for IV formulation of TPOXX
- 05/12/22
- Siga Technologies awarded $7.5M Department of Defense contract
- 05/05/22
- Siga Technologies announces special dividend of 45c per share
- 03/02/22
- Siga Technologies announces start of TPOXX PEP clinical trials
- 05/26/22
- PMV Pharmaceuticals: Lead program, PC14586 accepted as oral presentation at ASCO
- 04/27/22
- PMV Pharmaceuticals to present initial PC14586 Phase 1 data at ASCO
- 04/21/22
- Navient announces Lehman to leave board of directors
- 04/18/22
- Navient, Sherborne Investors enter cooperation agreement
- 04/01/22
- Navient sponsors USS Delaware commissioning commemoration event
- 02/14/22
- Cooperman's Omega added Mirion, Discovery and Gan in Q4
- 05/09/22
- Marvell to acquire Tanzanite in an all-cash transaction
- 04/20/22
- Marvell appoints Sara Andrews to board of directors
- 04/14/22
- Worldwide semiconductor revenue grew 26% in 2021, Gartner says
- 03/14/22
- Marvell CEO: The company is performing extremely well
- $39.80 /
-18.63 (-31.88%) - 05/27/22
- Mirati Therapeutics trading resumes
- 05/27/22
- Mirati Therapeutics trading halted, volatility trading pause
- 05/26/22
- Mirati Therapeutics says disease control rate was 80% in study
- 05/19/22
- Mirati Therapeutics submits adagrasib MAA to EMA
- 05/26/22
- Macy's rises 14.2%
- 05/26/22
- Macy's rises 16.9%
- 05/26/22
- Macy's jumps 12.5% to $21.61 after Q1 earnings beat
- 05/26/22
- Macy's reports Q1 digital sales up 2% y/y and 34% q/q
- 05/20/22
- iQIYI set to release 213 new pieces of content
- 04/25/22
- iQIYI launches third set of digital collectibles
- 04/01/22
- iQIYI to upgrade collaboration model for online film distribution
- 03/31/22
- iQIYI provides update on status under HFCAA
IOVA Iovance Biotherapeutics - 05/26/22
- Iovance announces clinical data for lifileucel in advanced melanoma
- 04/05/22
- Iovance Biotherapeutics provides regulatory update on lifileucel
- 03/15/22
- Iovance Biotherapeutics announces FDA allows IOV-4001 IND to proceed
- 01/10/22
- Iovance appoints Raj Puri as EVP, regulatory strategy, translational medicine
- 05/27/22
- Hibbett drops 7% to $47.50 after Q1 results miss estimates
- 05/27/22
- Hibbett CEO says 'supply chain disruption has improved, inventory strong'
- 03/04/22
- Hibbett reports Q4 SSS up 20.7% on two-year basis
- 03/04/22
- Hibbett sees FY23 CapEx $60M-$70M
- 05/27/22
- Gap falls -14.2%
- 05/27/22
- Gap trading resumes
- 05/27/22
- Gap trading halted, volatility trading pause
- 05/26/22
- Gap falls 14% to $9.60 after Q1 earnings miss and guidance cut
- 05/27/22
- Farfetch rises 22.8%
- 05/27/22
- Farfetch rises 14.7%
- 05/26/22
- Farfetch sees FY22 Digital GMV up 5%-10% and Brand Platform GMV up 10%-15%
- 04/05/22
- Farfetch, Neiman Marcus Group announce global strategic partnership
DIDI Symbol changed to DIDIY - 05/23/22
- Didi to proceed with delisting of shares from NYSE
- 05/16/22
- Paulson exits Cerner, boosts Didi in Q1
- 04/17/22
- DiDi to hold shareholder meeting on May 23 to vote on U.S. delisting plans
- 03/25/22
- Didi falls -13.4%
- $49.57 /
+5.715 (+13.03%) - 05/27/22
- Dell Technologies rises 14.2%
- 05/27/22
- Dell Technologies rises 18.1%
- 05/26/22
- Dell Technologies jumps 7% to $47.02 after Q1 results beat estimates
- 05/26/22
- Dell Technologies ended Q1 with performance obligations of $42B
- 05/04/22
- Costco reports April sales of $17.33B, up 13.9%
- 04/13/22
- Costco increases quarterly cash dividend to 90c per share
- 04/06/22
- Costco reports March sales of $21.61B, up 18.7%
- 03/08/22
- Jones Soda's Fountain Syrup now sold at Costco Business Centers
- 05/27/22
- Canopy Growth expects to be adjusted EBITDA positive in FY24
- 05/18/22
- Canopy Growth announces plans to acquire Jetty Extracts
- 04/26/22
- Canopy Growth expects to generate savings of $100M-$150M within 12-18 months
- 04/26/22
- Canopy Growth announces cost reduction initiatives including headcount reduction
- 01/28/22
- Boot Barn CEO: Plenty of opportunities to grow the business
- 01/27/22
- Boot Barn sees FY22 CapEx $41M-$43M
- 05/27/22
- Big Lots falls -10.3%
- 05/27/22
- Big Lots falls -16.0%
- 05/27/22
- Big Lots falls -11.7%
- 05/27/22
- Big Lots drops 18% to $25.00 after Q1 results miss estimates
- 05/27/22 UBS
- Gap price target lowered to $11 from $14 at UBS
- 05/27/22 Deutsche Bank
- Gap price target lowered to $12 from $17 at Deutsche Bank
- 05/27/22 Wells Fargo
- Gap price target lowered to $16 from $20 at Wells Fargo
- 05/27/22 Baird
- Gap price target lowered to $11 from $14 at Baird
- 05/27/22 DA Davidson
- Workday price target lowered to $220 from $250 at DA Davidson
- 05/27/22 Stifel
- Workday price target lowered to $220 from $275 at Stifel
- 05/27/22 BMO Capital
- Workday price target lowered to $239 from $249 at BMO Capital
- 05/27/22 Needham
- Workday price target lowered to $200 from $300 at Needham
- $425.30 /
+47.685 (+12.63%) - 05/27/22 DA Davidson
- Ulta Beauty price target raised to $465 from $450 at DA Davidson
- 05/27/22 Oppenheimer
- Ulta Beauty price target raised to $485 from $470 at Oppenheimer
- 05/27/22 Jefferies
- Jefferies upgrades Ulta Beauty to Buy after 'signal we'd been waiting for'
- 05/27/22 Baird
- Ulta Beauty price target raised to $490 from $450 at Baird
- $49.57 /
+5.715 (+13.03%) - 05/27/22 BofA
- Dell Technologies price target raised to $67 from $65 at BofA
- 05/27/22 Morgan Stanley
- Dell Technologies price target lowered to $56 from $60 at Morgan Stanley
- 05/27/22 Deutsche Bank
- Dell Technologies price target lowered to $60 from $65 at Deutsche Bank
- 05/25/22 Evercore ISI
- Dell Technologies added to 'Tactical Outperform' list at Evercore ISI
- 05/27/22 Truist
- Costco price target raised to $543 from $503 at Truist
- 05/27/22 Baird
- Costco price target lowered to $560 from $600 at Baird
- 05/27/22 Credit Suisse
- Costco price target lowered to $550 from $570 at Credit Suisse
- 05/27/22 Loop Capital
- Costco price target lowered to $610 from $650 at Loop Capital
- 05/27/22 Baird
- Boot Barn upgraded to Outperform from Neutral at Baird
- 05/11/22 Craig-Hallum
- Boot Barn price target lowered to $145 from $162 at Craig-Hallum
- 05/11/22 JPMorgan
- Boot Barn added to Analyst Focus List at JPMorgan
- 05/06/22 Piper Sandler
- Boot Barn upgraded to Overweight from Neutral at Piper Sandler
- $159.88 /
+17.55 (+12.33%) - 05/27/22 Cowen
- Zscaler price target lowered to $194 from $405 at Cowen
- 05/27/22 Canaccord
- Zscaler price target lowered to $210 from $320 at Canaccord
- 05/27/22 BMO Capital
- Zscaler price target lowered to $172 from $270 at BMO Capital
- 05/27/22 Baird
- Zscaler price target lowered to $200 from $300 at Baird
- 05/27/22 BMO Capital
- Marvell price target lowered to $82 from $98 at BMO Capital
- 05/27/22 Needham
- Marvell price target lowered to $75 from $105 at Needham
- 05/27/22 BofA
- Marvell price target lowered to $90 from $100 at BofA
- 05/27/22 Cowen
- Marvell price target lowered to $85 from $100 at Cowen
- 05/25/22 Deutsche Bank
- Big Lots price target lowered to $31 from $44 at Deutsche Bank
- 05/24/22 BofA
- Big Lots price target lowered to $25 from $31 at BofA
- 05/20/22 Piper Sandler
- Big Lots price target lowered to $29 from $34 at Piper Sandler
- 05/10/22 JPMorgan
- Big Lots price target lowered to $25 from $31 at JPMorgan
- 05/20/22 Benchmark
- Benchmark says Emergent, Siga, Chimerix strength attributable to monkeypox scare
- 05/27/22 Deutsche Bank
- Macy's price target lowered to $29 from $34 at Deutsche Bank
- 05/27/22 Citi
- Macy's price target lowered to $23 from $25 at Citi
- 05/27/22 Morgan Stanley
- Macy's upgraded to Equal Weight from Underweight at Morgan Stanley
- 05/16/22 JPMorgan
- Macy's price target lowered to $30 from $33 at JPMorgan
- 05/27/22 Benchmark
- iQIYI upgraded to Buy from Hold at Benchmark
- 05/26/22 Citi
- Citi upgrades iQIYI on earlier than expected profitability
- 05/26/22 Citi
- iQIYI upgraded to Buy from Neutral at Citi
- 05/16/22 JPMorgan
- iQIYI upgraded to Overweight from Underweight at JPMorgan
- 05/26/22 Bernstein
- UnitedHealth downgraded to Market Perform at Bernstein on valuation
- 05/26/22 Bernstein
- UnitedHealth downgraded to Market Perform from Outperform at Bernstein
- 05/11/22 Citi
- MultiPlan price target raised to $6.50 from $6 at Citi
- 04/26/22 Piper Sandler
- Piper 'incrementally confident' Change, UNH will prevail in August
- 05/27/22 Alliance Global Partners
- Canopy Growth price target lowered to C$7 from C$8 at Alliance Global Partners
- 05/27/22 Benchmark
- Canopy Growth cut to Sell at Benchmark after 'disappointing' quarter
- 05/27/22 Benchmark
- Canopy Growth downgraded to Sell from Hold at Benchmark
- 05/20/22 Alliance Global Partners
- Canopy Growth price target lowered to C$8 from C$11 at Alliance Global Partners
- $15.65 /
-0.1601 (-1.01%) - 05/18/22 RBC Capital
- Reckitt Benckiser upgraded to Outperform from Sector Perform at RBC Capital
- 05/09/22 Morgan Stanley
- Reckitt Benckiser price target raised to 7,100 GBp at Morgan Stanley
- 05/03/22 RBC Capital
- Reckitt Benckiser price target raised to 5,900 GBp at RBC Capital
- 05/03/22 Barclays
- Reckitt Benckiser price target raised to 9,300 GBp from 9,100 GBp at Barclays
- 04/11/22 JPMorgan
- Navient cut to Underweight at JPMorgan on student lending normalization delay
- 04/11/22 JPMorgan
- Navient downgraded to Underweight from Neutral at JPMorgan
- 03/31/22 Compass Point
- Navient downgraded to Neutral from Buy at Compass Point
- 01/27/22 JPMorgan
- Navient price target lowered to $21 from $23 at JPMorgan
- 05/17/22 Mizuho
- SoFi Technologies price target lowered to $9 from $14 at Mizuho
- 05/16/22 Piper Sandler
- Piper upgrades SoFi to buy ahead of 'significant' earnings ramp
- 05/16/22 Piper Sandler
- SoFi Technologies upgraded to Overweight from Neutral at Piper Sandler
- 05/12/22 Citi
- SoFi Technologies price target lowered to $11 from $17 at Citi
- 01/13/22 Credit Suisse
- Nelnet downgraded to Neutral from Outperform at Credit Suisse
- 05/02/22 Citi
- Sallie Mae price target lowered to $21 from $26 at Citi
- 04/18/22 Stephens
- Sallie Mae downgraded to Equal Weight from Overweight at Stephens
- 01/10/22 Barclays
- Sallie Mae price target raised to $27 from $25 at Barclays
- 07/22/21 Stephens
- Stephens 'surprised' by Sallie Mae stock underperformance, ups target to $23
DIDI Symbol changed to DIDIY - 03/16/22 US Tiger
- China Internet sector upgraded to Outperform from Neutral at US Tiger
- 02/14/22 Bernstein
- Didi initiated with an Outperform at Bernstein
- 07/28/21 Alliance Global Partners
- Alliance Global Partners bullish on Aurora Mobile despite regulatory changes
- 07/28/21 Alliance Global Partners
- iClick Interactive price target lowered to $15 from $21 at Alliance Global
- 05/24/22 Jefferies
- Twitter price target lowered to $40 from $48 at Jefferies
- 05/24/22 Wedbush
- More fireworks expected heading into Twitter shareholder meeting, says Wedbush
- 05/24/22 KeyBanc
- Snap price target lowered to $27 from $45 at KeyBanc
- 05/24/22 Bernstein
- Bernstein says Tesla-Twitter saga far from over, discusses funding requirements
- $759.79 /
+52.67 (+7.45%) - 05/27/22 Credit Suisse
- Tesla pullback brings attractive entry point, says Credit Suisse
- 05/26/22 Jefferies
- Jefferies cuts Tesla price target on governance risk, challenging market
- 05/27/22 Wedbush
- Farfetch price target lowered to $8 from $16 at Wedbush
- 05/27/22 Morgan Stanley
- Farfetch price target lowered to $30 from $56 at Morgan Stanley
- 05/27/22 Wells Fargo
- Farfetch price target lowered to $25 from $35 at Wells Fargo
- 05/27/22 BTIG
- Farfetch price target lowered to $16 from $26 at BTIG
- 03/02/22 Oppenheimer
- Oppenheimer upgrades PMV Pharmaceuticals to Outperform with $30 price target
- 03/02/22 Oppenheimer
- PMV Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer
- 09/22/21 Goldman Sachs
- PMV Pharmaceuticals upgraded to Buy from Neutral at Goldman Sachs
- 08/19/21 Oppenheimer
- PMV Pharmaceuticals initiated with a Perform at Oppenheimer
IOVA Iovance Biotherapeutics - 05/27/22 H.C. Wainwright
- Iovance Biotherapeutics 'close to the finish line,' says H.C. Wainwright
- 05/27/22 Oppenheimer
- Iovance Biotherapeutics price target lowered to $27 from $31 at Oppenheimer
- 05/27/22 Stifel
- Iovance Biotherapeutics after-hours stock reaction seems 'overdone,' says Stifel
- 05/27/22 Chardan
- Iovance Biotherapeutics price target lowered to $31 from $44 at Chardan
- $39.80 /
-18.63 (-31.88%) - 05/27/22 Stifel
- Mirati Therapeutics after-hours move lower 'overdone,' says Stifel
- 05/20/22 Guggenheim
- Guggenheim upgrades Mirati to Buy on adagrasib's 'highly competitive profile'
- 05/20/22 Guggenheim
- Mirati Therapeutics upgraded to Buy from Neutral at Guggenheim
- 05/05/22 Stifel
- ASCO sets up as 'downside-biased' for Mirati investors, says Stifel
- 05/25/22 MKM Partners
- Wendy's may see more 'value unlocks' from strategic options, says MKM Partners
- 05/25/22 Wedbush
- Wedbush remains bullish on Wendy's, not surprised by Trian news
- 05/25/22 Stifel
- Wendy's deal in 'low-$20 range' would be 'feasible,' says Stifel
- 05/12/22 Truist
- Wendy's price target lowered to $27 from $29 at Truist
- 05/27/22 Baird
- Hibbett price target lowered to $70 from $75 at Baird
- 03/07/22 Benchmark
- Hibbett price target lowered to $80 from $125 at Benchmark
- 02/22/22 Monness Crespi
- Hibbett price target lowered to $80 from $120 at Monness Crespi
- 02/21/22 Baird
- Hibbett price target lowered to $75 from $100 at Baird
- $159.88 /
+17.55 (+12.33%) - 05/26/22
- Zscaler sees FY22 EPS 64c-65c, consensus $55c
- 05/26/22
- Zscaler sees Q4 EPS 20c-22c, consensus 17c
- 05/26/22
- Zscaler reports Q3 EPS 17c, consensus 11c
- 05/26/22
- Wendy's affirms FY22 EPS view at 82c-86c, consensus 83c, postpones Investor Day
- 05/11/22
- Wendy's backs FY22 adjusted EPS view 82c-86c, consensus 87c
- 05/11/22
- Wendy's reports Q1 adjusted EPS 17c, consensus 18c
- 05/10/22
- Notable companies reporting before tomorrow's open
- 05/26/22
- Workday sees Q2 subscription revenue $1.353B-$1.355B
- 05/26/22
- Workday raises FY23 subscription revenue view to $5.537B-$5.557B
- 05/26/22
- Workday reports Q1 EPS 83c, consensus 86c
- 04/14/22
- UnitedHealth raises FY22 adjusted EPS view to $21.20-$21.70 from $21.10-$21.60
- 04/14/22
- UnitedHealth reports Q1 adjusted EPS $5.49, consensus $5.38
- 04/13/22
- Notable companies reporting before tomorrow's open
- $425.30 /
+47.685 (+12.63%) - 05/26/22
- Ulta Beauty raises FY22 EPS view to $19.20-$20.10 from $18.20-$18.70
- 05/26/22
- Ulta Beauty reports Q1 EPS $6.30, consensus $4.46
- 03/10/22
- Ulta Beauty sees FY2 EPS $18.20-$18.70, consensus $17.84
- 04/28/22
- Twitter withdrawing previously provided outlook given pending acquisition
- 04/28/22
- Twitter reports Q1 EPS 90c, consensus 3c
- 02/10/22
- Twitter expects FY22 revenue growth in low to mid 20's range
- 02/10/22
- Twitter sees Q1 revenue $1.17B-$1.27B, consensus $1.26B
- $759.79 /
+52.67 (+7.45%) - 04/20/22
- Tesla reports Q1 EPS $3.22, consensus $2.26
- 04/20/22
- Notable companies reporting after market close
- 01/26/22
- Tesla reports Q4 non-GAAP EPS $2.54, consensus $2.26
- 01/26/22
- Notable companies reporting after market close
- 05/10/22
- SoFi Technologies sees FY22 adjusted revenue $1.505B-$1.51B, consensus $1.46B
- 05/10/22
- SoFi Technologies sees Q2 adjusted net revenue $330M-$340M, consensus $343.9M
- 05/10/22
- SoFi Technologies reports Q1 EPS (14c), consensus (14c)
- 05/10/22
- SoFi Technologies sees FY22 adjusted revenue $1.51B, Bloomberg says
- 04/27/22
- Sallie Mae sees FY22 core EPS $2.80-$3.00, consensus $2.95
- 04/27/22
- Sallie Mae reports Q1 core EPS 46c, consensus 82c
- 04/27/22
- Notable companies reporting after market close
- 01/26/22
- Sallie Mae reports Q4 core EPS $1.05, consensus 97c
- 03/03/22
- Siga Technologies reports Q 4EPS 98c versus 26c last year
- 05/10/22
- PMV Pharmaceuticals reports Q1 EPS (41c), consensus (40c)
- 03/01/22
- PMV Pharmaceuticals reports 2021 EPS ($1.28), consensus ($1.22)
- 04/27/22
- Navient raises FY22 EPS view to $3.20-$3.30 from $3.00-$3.15, consensus $3.03
- 04/26/22
- Navient reports Q1 adjusted EPS 90c, consensus 75c
- 04/26/22
- Notable companies reporting after market close
- 01/26/22
- Navient sees FY22 EPS $3.00-$3.15, consensus $3.12
- 05/26/22
- Marvell sees Q2 adjusted EPS 56c, +/- 3c per share, consensus 55c
- 05/26/22
- Marvell reports Q1 adjusted EPS 52c, consensus 51c
- 03/03/22
- Marvell sees Q1 adjusted EPS 51c +/- 3c, consensus 50c
- $39.80 /
-18.63 (-31.88%) - 02/28/22
- Mirati Therapeutics reports Q4 EPS ($3.72), consensus ($3.00)
- 02/28/22
- Mirati Therapeutics reports Q4 EPS ($3072), consensus ($3.00)
- 05/26/22
- Macy's raises FY22 EPS view to $4.53-$4.95 from $4.13-$4.52, consensus $4.34
- 05/26/22
- Macy's reports Q1 EPS $1.08, consensus 82c
- 05/25/22
- Notable companies reporting before tomorrow's open
- 05/26/22
- iQIYI reports Q1 EPS 3c, consensus (11c)
- 03/01/22
- iQIYI reports Q4 EPS (20c), consensus (32c)
IOVA Iovance Biotherapeutics - 05/05/22
- Iovance Biotherapeutics reports Q1 EPS (58c), consensus (64c)
- 05/27/22
- Hibbett backs FY23 EPS view $9.75-$10.50, consensus $9.74
- 05/27/22
- Hibbett reports Q1 EPS $2.89, consensus $3.08
- 03/04/22
- Hibbett sees FY23 EPS $9.75-$10.50, consensus $9.85
- 03/04/22
- Hibbett reports Q4 EPS $1.25, consensus $1.35
- 05/26/22
- Gap cuts FY22 revenue view to down low-mid single digits from low single digits
- 05/26/22
- Gap cuts FY22 EPS view to 30c-60c from $1.85-$2.05
- 05/26/22
- Gap reports Q1 EPS (44c), consensus (13c)
- 05/26/22
- Notable companies reporting after market close
- 05/26/22
- Farfetch reports Q1 EPS (24c), consensus (28c)
- 02/24/22
- Farfetch reports Q4 adjusted EPS (3c), consensus (3c)
DIDI Symbol changed to DIDIY - 12/29/21
- Didi reports Q2 net loss (RMB 24.3B) vs. (RMB 63M) last year
- $49.57 /
+5.715 (+13.03%) - 05/26/22
- Dell Technologies reports Q1 adjusted EPS $1.84, consensus $1.39
- 02/24/22
- Dell Technologies reports Q4 adjusted EPS $1.72, consensus $1.95
- 02/24/22
- Notable companies reporting after market close
- 05/26/22
- Costco reports Q3 EPS $3.04, consensus $3.03
- 03/03/22
- Costco reports Q2 EPS $2.92, consensus $2.74
- 03/03/22
- Notable companies reporting after market close
- 05/27/22
- Canopy Growth reports Q4 EPS (C$1.46) vs. (C$1.85) a year ago
- 04/07/22
- Constellation Brands reports Q4 comparable EPS ex-Canopy losses $2.55
- 02/09/22
- Canopy Growth reports Q3 EPS (C$0.28) vs. (C$2.43) a year ago
- 05/10/22
- Boot Barn sees Q1 EPS $1.14, consensus $1.11
- 05/10/22
- Boot Barn sees FY23 EPS $6.41, consensus $5.56
- 05/10/22
- Boot Barn reports Q4 EPS $1.47, consensus $1.32
- 01/27/22
- Boot Barn reports Q3 EPS $2.23 ex-items, consensus $2.22
- 05/27/22
- Big Lots reports Q1 EPS (39c), consensus 93c
- 03/03/22
- Big Lots sees Q1 adjusted EPS $1.10-$1.20, consensus $1.28
- 03/03/22
- Big Lots reports Q4 adjusted EPS $1.75, consensus $1.89
- 01/10/22
- Big Lots sees Q4 performance at 'upper end' of expectations
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - $157.14 /
+14.81 (+10.41%) - 05/02/22
- Zscaler appoints Castle as Chief People Officer
- 04/13/22
- Synchronoss appoints Stanley Lowe as chief information security officer
- 12/22/21
- Zscaler officer Rajic sells $7.9M in company shares
- 12/20/21
- Zscaler CFO sells $4.47M in common stock
- 05/24/22
- Wendy's board to 'carefully review any proposal submitted by Trian Partners'
- 05/24/22
- Wendy's up 15% to $18.70 following Trian 13D/A filing on potential transaction
- 05/24/22
- Wendy's shareholder Trian to explore potential transaction
- 05/14/22
- Trian exits Comcast position, increases stake in Invesco
- $152.90 /
-15.16 (-9.02%) - 05/26/22
- Workday drops 7% to $155.50 after Q1 EPS misses estimates
- 05/16/22
- Lone Pine adds TSMC in Q1, exits KE Holdings and Adobe
- 02/28/22
- Workday sees FY23 subscription revenue at $5.53B-$5.55B, up 22% y/y
- 02/14/22
- Lone Pine takes stakes in Mastercard, Visa, exits Twitter, Meta Platforms
- 05/16/22
- Soros Capital buys Suncor and Mosaic during Q1, exits Alphabet
- 05/12/22
- UnitedHealth selected by State of Missouri to serve Medicaid beneficiaries
- 04/26/22
- Change says UnitedHealth to sell ClaimsXten for $2.2B if deal closes
- $414.47 /
+36.855 (+9.76%) - 05/26/22
- Ulta Beauty jumps 7.6% to $406.50 after Q1 earnings beat and guidance raise
- 05/19/22
- Ulta Beauty launches retail media network UB Media
- 03/28/22
- PayPal broadens access to post purchase services for merchants
- 03/11/22
- Ulta Beauty approves new $2B share repurchase authorization
- 05/27/22
- Twitter board does not accept resignation of Silver Lake's Egon Durban
- 05/25/22
- Twitter up 9% after Elon Musk files amended 13D related to takeover agreement
- 05/25/22
- Musk commits to provide additional $6.25B in equity financing for Twitter deal
- 05/20/22
- Elon Musk: We will never surrender/settle an unjust case against us
- $752.74 /
+45.62 (+6.45%) - 05/24/22
- Cathie Wood's ARK Investment bought 26.1K shares of Tesla today
- 05/23/22
- Cathie Wood's ARK Investment bought 15.9K shares of Tesla today
- 05/20/22
- Musk denies he sexually harassed flight attendant on private jet
- 05/10/22
- SoFi Technologies off lows after resumption, remains down 13%
- 05/10/22
- SoFi Technologies trading resumes
- 05/10/22
- SoFi Technologies to resume trading at 2:10 pm ET
- 05/10/22
- SoFi Technologies CEO says 'off to a great start' standing up bank
- 03/24/22
- Sallie Mae appoints William Wolf as CPO
- 01/26/22
- Sallie Mae board approves new $1.25B share repurchase program
- 01/26/22
- Sallie Mae to acquire Nitro College, terms not disclosed
- 05/19/22
- Siga Technologies receives FDA approval for IV formulation of TPOXX
- 05/12/22
- Siga Technologies awarded $7.5M Department of Defense contract
- 05/05/22
- Siga Technologies announces special dividend of 45c per share
- 03/02/22
- Siga Technologies announces start of TPOXX PEP clinical trials
- 05/26/22
- PMV Pharmaceuticals: Lead program, PC14586 accepted as oral presentation at ASCO
- 04/27/22
- PMV Pharmaceuticals to present initial PC14586 Phase 1 data at ASCO
- 04/21/22
- Navient announces Lehman to leave board of directors
- 04/18/22
- Navient, Sherborne Investors enter cooperation agreement
- 04/01/22
- Navient sponsors USS Delaware commissioning commemoration event
- 02/14/22
- Cooperman's Omega added Mirion, Discovery and Gan in Q4
- 05/09/22
- Marvell to acquire Tanzanite in an all-cash transaction
- 04/20/22
- Marvell appoints Sara Andrews to board of directors
- 04/14/22
- Worldwide semiconductor revenue grew 26% in 2021, Gartner says
- 03/14/22
- Marvell CEO: The company is performing extremely well
- $38.54 /
-19.89 (-34.04%) - 05/27/22
- Mirati Therapeutics trading resumes
- 05/27/22
- Mirati Therapeutics trading halted, volatility trading pause
- 05/26/22
- Mirati Therapeutics says disease control rate was 80% in study
- 05/19/22
- Mirati Therapeutics submits adagrasib MAA to EMA
- 05/26/22
- Medtronic: Q1 EPS guidance includes FX headwind of about 5c
- 05/26/22
- Medtronic: Procedure volumes in most markets reached pre-Covid levels by Q4E
- 05/26/22
- Medtronic sees 'strong' improvement in 2H23, pipeline 'robust'
- 05/26/22
- Medtronic: Parts of quarter played out as anticipated, but unexpected challenges
- 05/26/22
- Macy's rises 14.2%
- 05/26/22
- Macy's rises 16.9%
- 05/26/22
- Macy's jumps 12.5% to $21.61 after Q1 earnings beat
- 05/26/22
- Macy's reports Q1 digital sales up 2% y/y and 34% q/q
- 05/20/22
- iQIYI set to release 213 new pieces of content
- 04/25/22
- iQIYI launches third set of digital collectibles
- 04/01/22
- iQIYI to upgrade collaboration model for online film distribution
- 03/31/22
- iQIYI provides update on status under HFCAA
IOVA Iovance Biotherapeutics - 05/26/22
- Iovance announces clinical data for lifileucel in advanced melanoma
- 04/05/22
- Iovance Biotherapeutics provides regulatory update on lifileucel
- 03/15/22
- Iovance Biotherapeutics announces FDA allows IOV-4001 IND to proceed
- 01/10/22
- Iovance appoints Raj Puri as EVP, regulatory strategy, translational medicine
- 05/27/22
- Hibbett drops 7% to $47.50 after Q1 results miss estimates
- 05/27/22
- Hibbett CEO says 'supply chain disruption has improved, inventory strong'
- 03/04/22
- Hibbett reports Q4 SSS up 20.7% on two-year basis
- 03/04/22
- Hibbett sees FY23 CapEx $60M-$70M
- 05/27/22
- Gap falls -14.2%
- 05/27/22
- Gap trading resumes
- 05/27/22
- Gap trading halted, volatility trading pause
- 05/26/22
- Gap falls 14% to $9.60 after Q1 earnings miss and guidance cut
- 05/27/22
- Farfetch rises 22.8%
- 05/27/22
- Farfetch rises 14.7%
- 05/26/22
- Farfetch sees FY22 Digital GMV up 5%-10% and Brand Platform GMV up 10%-15%
- 04/05/22
- Farfetch, Neiman Marcus Group announce global strategic partnership
DIDI Symbol changed to DIDIY - 05/23/22
- Didi to proceed with delisting of shares from NYSE
- 05/16/22
- Paulson exits Cerner, boosts Didi in Q1
- 04/17/22
- DiDi to hold shareholder meeting on May 23 to vote on U.S. delisting plans
- 03/25/22
- Didi falls -13.4%
- 05/27/22
- Dell Technologies rises 14.2%
- 05/27/22
- Dell Technologies rises 18.1%
- 05/26/22
- Dell Technologies jumps 7% to $47.02 after Q1 results beat estimates
- 05/26/22
- Dell Technologies ended Q1 with performance obligations of $42B
- 05/04/22
- Costco reports April sales of $17.33B, up 13.9%
- 04/13/22
- Costco increases quarterly cash dividend to 90c per share
- 04/06/22
- Costco reports March sales of $21.61B, up 18.7%
- 03/08/22
- Jones Soda's Fountain Syrup now sold at Costco Business Centers
- 01/28/22
- Boot Barn CEO: Plenty of opportunities to grow the business
- 01/27/22
- Boot Barn sees FY22 CapEx $41M-$43M
- 05/27/22
- Big Lots falls -10.3%
- 05/27/22
- Big Lots falls -16.0%
- 05/27/22
- Big Lots falls -11.7%
- 05/27/22
- Big Lots drops 18% to $25.00 after Q1 results miss estimates
- 05/27/22 UBS
- Gap price target lowered to $11 from $14 at UBS
- 05/27/22 Deutsche Bank
- Gap price target lowered to $12 from $17 at Deutsche Bank
- 05/27/22 Wells Fargo
- Gap price target lowered to $16 from $20 at Wells Fargo
- 05/27/22 Baird
- Gap price target lowered to $11 from $14 at Baird
- $152.90 /
-15.16 (-9.02%) - 05/27/22 DA Davidson
- Workday price target lowered to $220 from $250 at DA Davidson
- 05/27/22 Stifel
- Workday price target lowered to $220 from $275 at Stifel
- 05/27/22 BMO Capital
- Workday price target lowered to $239 from $249 at BMO Capital
- 05/27/22 Needham
- Workday price target lowered to $200 from $300 at Needham
- $414.47 /
+36.855 (+9.76%) - 05/27/22 DA Davidson
- Ulta Beauty price target raised to $465 from $450 at DA Davidson
- 05/27/22 Oppenheimer
- Ulta Beauty price target raised to $485 from $470 at Oppenheimer
- 05/27/22 Jefferies
- Jefferies upgrades Ulta Beauty to Buy after 'signal we'd been waiting for'
- 05/27/22 Baird
- Ulta Beauty price target raised to $490 from $450 at Baird
- 05/27/22 BofA
- Dell Technologies price target raised to $67 from $65 at BofA
- 05/27/22 Morgan Stanley
- Dell Technologies price target lowered to $56 from $60 at Morgan Stanley
- 05/27/22 Deutsche Bank
- Dell Technologies price target lowered to $60 from $65 at Deutsche Bank
- 05/25/22 Evercore ISI
- Dell Technologies added to 'Tactical Outperform' list at Evercore ISI
- 05/27/22 Truist
- Costco price target raised to $543 from $503 at Truist
- 05/27/22 Baird
- Costco price target lowered to $560 from $600 at Baird
- 05/27/22 Credit Suisse
- Costco price target lowered to $550 from $570 at Credit Suisse
- 05/27/22 Loop Capital
- Costco price target lowered to $610 from $650 at Loop Capital
- 05/27/22 Baird
- Boot Barn upgraded to Outperform from Neutral at Baird
- 05/11/22 Craig-Hallum
- Boot Barn price target lowered to $145 from $162 at Craig-Hallum
- 05/11/22 JPMorgan
- Boot Barn added to Analyst Focus List at JPMorgan
- 05/06/22 Piper Sandler
- Boot Barn upgraded to Overweight from Neutral at Piper Sandler
- $157.14 /
+14.81 (+10.41%) - 05/27/22 Cowen
- Zscaler price target lowered to $194 from $405 at Cowen
- 05/27/22 Canaccord
- Zscaler price target lowered to $210 from $320 at Canaccord
- 05/27/22 BMO Capital
- Zscaler price target lowered to $172 from $270 at BMO Capital
- 05/27/22 Baird
- Zscaler price target lowered to $200 from $300 at Baird
- 05/27/22 BMO Capital
- Marvell price target lowered to $82 from $98 at BMO Capital
- 05/27/22 Needham
- Marvell price target lowered to $75 from $105 at Needham
- 05/27/22 BofA
- Marvell price target lowered to $90 from $100 at BofA
- 05/27/22 Cowen
- Marvell price target lowered to $85 from $100 at Cowen
- 05/25/22 Deutsche Bank
- Big Lots price target lowered to $31 from $44 at Deutsche Bank
- 05/24/22 BofA
- Big Lots price target lowered to $25 from $31 at BofA
- 05/20/22 Piper Sandler
- Big Lots price target lowered to $29 from $34 at Piper Sandler
- 05/10/22 JPMorgan
- Big Lots price target lowered to $25 from $31 at JPMorgan
- 05/20/22 Benchmark
- Benchmark says Emergent, Siga, Chimerix strength attributable to monkeypox scare
- 05/27/22 Deutsche Bank
- Macy's price target lowered to $29 from $34 at Deutsche Bank
- 05/27/22 Citi
- Macy's price target lowered to $23 from $25 at Citi
- 05/27/22 Morgan Stanley
- Macy's upgraded to Equal Weight from Underweight at Morgan Stanley
- 05/16/22 JPMorgan
- Macy's price target lowered to $30 from $33 at JPMorgan
- 05/27/22 Benchmark
- iQIYI upgraded to Buy from Hold at Benchmark
- 05/26/22 Citi
- Citi upgrades iQIYI on earlier than expected profitability
- 05/26/22 Citi
- iQIYI upgraded to Buy from Neutral at Citi
- 05/16/22 JPMorgan
- iQIYI upgraded to Overweight from Underweight at JPMorgan
- 05/26/22 Bernstein
- UnitedHealth downgraded to Market Perform at Bernstein on valuation
- 05/26/22 Bernstein
- UnitedHealth downgraded to Market Perform from Outperform at Bernstein
- 05/11/22 Citi
- MultiPlan price target raised to $6.50 from $6 at Citi
- 04/26/22 Piper Sandler
- Piper 'incrementally confident' Change, UNH will prevail in August
- 05/27/22 RBC Capital
- Medtronic price target lowered to $122 from $135 at RBC Capital
- 05/27/22 Cowen
- Medtronic price target lowered to $117 from $125 at Cowen
- 05/27/22 Needham
- Medtronic downgraded to Hold at Needham on slowing revenue growth
- 05/27/22 Deutsche Bank
- Medtronic price target lowered to $121 from $149 at Deutsche Bank
- 05/18/22 RBC Capital
- Reckitt Benckiser upgraded to Outperform from Sector Perform at RBC Capital
- 05/09/22 Morgan Stanley
- Reckitt Benckiser price target raised to 7,100 GBp at Morgan Stanley
- 05/03/22 RBC Capital
- Reckitt Benckiser price target raised to 5,900 GBp at RBC Capital
- 05/03/22 Barclays
- Reckitt Benckiser price target raised to 9,300 GBp from 9,100 GBp at Barclays
- 04/11/22 JPMorgan
- Navient cut to Underweight at JPMorgan on student lending normalization delay
- 04/11/22 JPMorgan
- Navient downgraded to Underweight from Neutral at JPMorgan
- 03/31/22 Compass Point
- Navient downgraded to Neutral from Buy at Compass Point
- 01/27/22 JPMorgan
- Navient price target lowered to $21 from $23 at JPMorgan
- 05/17/22 Mizuho
- SoFi Technologies price target lowered to $9 from $14 at Mizuho
- 05/16/22 Piper Sandler
- Piper upgrades SoFi to buy ahead of 'significant' earnings ramp
- 05/16/22 Piper Sandler
- SoFi Technologies upgraded to Overweight from Neutral at Piper Sandler
- 05/12/22 Citi
- SoFi Technologies price target lowered to $11 from $17 at Citi
- 01/13/22 Credit Suisse
- Nelnet downgraded to Neutral from Outperform at Credit Suisse
- 05/02/22 Citi
- Sallie Mae price target lowered to $21 from $26 at Citi
- 04/18/22 Stephens
- Sallie Mae downgraded to Equal Weight from Overweight at Stephens
- 01/10/22 Barclays
- Sallie Mae price target raised to $27 from $25 at Barclays
- 07/22/21 Stephens
- Stephens 'surprised' by Sallie Mae stock underperformance, ups target to $23
DIDI Symbol changed to DIDIY - 03/16/22 US Tiger
- China Internet sector upgraded to Outperform from Neutral at US Tiger
- 02/14/22 Bernstein
- Didi initiated with an Outperform at Bernstein
- 07/28/21 Alliance Global Partners
- Alliance Global Partners bullish on Aurora Mobile despite regulatory changes
- 07/28/21 Alliance Global Partners
- iClick Interactive price target lowered to $15 from $21 at Alliance Global
- 05/24/22 Jefferies
- Twitter price target lowered to $40 from $48 at Jefferies
- 05/24/22 Wedbush
- More fireworks expected heading into Twitter shareholder meeting, says Wedbush
- 05/24/22 KeyBanc
- Snap price target lowered to $27 from $45 at KeyBanc
- 05/24/22 Bernstein
- Bernstein says Tesla-Twitter saga far from over, discusses funding requirements
- $752.74 /
+45.62 (+6.45%) - 05/27/22 Credit Suisse
- Tesla pullback brings attractive entry point, says Credit Suisse
- 05/26/22 Jefferies
- Jefferies cuts Tesla price target on governance risk, challenging market
- 05/27/22 Wedbush
- Farfetch price target lowered to $8 from $16 at Wedbush
- 05/27/22 Morgan Stanley
- Farfetch price target lowered to $30 from $56 at Morgan Stanley
- 05/27/22 Wells Fargo
- Farfetch price target lowered to $25 from $35 at Wells Fargo
- 05/27/22 BTIG
- Farfetch price target lowered to $16 from $26 at BTIG
- 03/02/22 Oppenheimer
- Oppenheimer upgrades PMV Pharmaceuticals to Outperform with $30 price target
- 03/02/22 Oppenheimer
- PMV Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer
- 09/22/21 Goldman Sachs
- PMV Pharmaceuticals upgraded to Buy from Neutral at Goldman Sachs
- 08/19/21 Oppenheimer
- PMV Pharmaceuticals initiated with a Perform at Oppenheimer
IOVA Iovance Biotherapeutics - 05/27/22 H.C. Wainwright
- Iovance Biotherapeutics 'close to the finish line,' says H.C. Wainwright
- 05/27/22 Oppenheimer
- Iovance Biotherapeutics price target lowered to $27 from $31 at Oppenheimer
- 05/27/22 Stifel
- Iovance Biotherapeutics after-hours stock reaction seems 'overdone,' says Stifel
- 05/27/22 Chardan
- Iovance Biotherapeutics price target lowered to $31 from $44 at Chardan
- $38.54 /
-19.89 (-34.04%) - 05/27/22 Stifel
- Mirati Therapeutics after-hours move lower 'overdone,' says Stifel
- 05/20/22 Guggenheim
- Guggenheim upgrades Mirati to Buy on adagrasib's 'highly competitive profile'
- 05/20/22 Guggenheim
- Mirati Therapeutics upgraded to Buy from Neutral at Guggenheim
- 05/05/22 Stifel
- ASCO sets up as 'downside-biased' for Mirati investors, says Stifel
- 05/25/22 MKM Partners
- Wendy's may see more 'value unlocks' from strategic options, says MKM Partners
- 05/25/22 Wedbush
- Wedbush remains bullish on Wendy's, not surprised by Trian news
- 05/25/22 Stifel
- Wendy's deal in 'low-$20 range' would be 'feasible,' says Stifel
- 05/12/22 Truist
- Wendy's price target lowered to $27 from $29 at Truist
- 03/07/22 Benchmark
- Hibbett price target lowered to $80 from $125 at Benchmark
- 02/22/22 Monness Crespi
- Hibbett price target lowered to $80 from $120 at Monness Crespi
- 02/21/22 Baird
- Hibbett price target lowered to $75 from $100 at Baird
- 12/06/21
- Fly Intel: Top five analyst upgrades
- $157.14 /
+14.81 (+10.41%) - 05/26/22
- Zscaler sees FY22 EPS 64c-65c, consensus $55c
- 05/26/22
- Zscaler sees Q4 EPS 20c-22c, consensus 17c
- 05/26/22
- Zscaler reports Q3 EPS 17c, consensus 11c
- 05/26/22
- Wendy's affirms FY22 EPS view at 82c-86c, consensus 83c, postpones Investor Day
- 05/11/22
- Wendy's backs FY22 adjusted EPS view 82c-86c, consensus 87c
- 05/11/22
- Wendy's reports Q1 adjusted EPS 17c, consensus 18c
- 05/10/22
- Notable companies reporting before tomorrow's open
- $152.90 /
-15.16 (-9.02%) - 05/26/22
- Workday sees Q2 subscription revenue $1.353B-$1.355B
- 05/26/22
- Workday raises FY23 subscription revenue view to $5.537B-$5.557B
- 05/26/22
- Workday reports Q1 EPS 83c, consensus 86c
- 04/14/22
- UnitedHealth raises FY22 adjusted EPS view to $21.20-$21.70 from $21.10-$21.60
- 04/14/22
- UnitedHealth reports Q1 adjusted EPS $5.49, consensus $5.38
- 04/13/22
- Notable companies reporting before tomorrow's open
- $414.47 /
+36.855 (+9.76%) - 05/26/22
- Ulta Beauty raises FY22 EPS view to $19.20-$20.10 from $18.20-$18.70
- 05/26/22
- Ulta Beauty reports Q1 EPS $6.30, consensus $4.46
- 03/10/22
- Ulta Beauty sees FY2 EPS $18.20-$18.70, consensus $17.84
- 04/28/22
- Twitter withdrawing previously provided outlook given pending acquisition
- 04/28/22
- Twitter reports Q1 EPS 90c, consensus 3c
- 02/10/22
- Twitter expects FY22 revenue growth in low to mid 20's range
- 02/10/22
- Twitter sees Q1 revenue $1.17B-$1.27B, consensus $1.26B
- $752.74 /
+45.62 (+6.45%) - 04/20/22
- Tesla reports Q1 EPS $3.22, consensus $2.26
- 04/20/22
- Notable companies reporting after market close
- 01/26/22
- Tesla reports Q4 non-GAAP EPS $2.54, consensus $2.26
- 01/26/22
- Notable companies reporting after market close
- 05/10/22
- SoFi Technologies sees FY22 adjusted revenue $1.505B-$1.51B, consensus $1.46B
- 05/10/22
- SoFi Technologies sees Q2 adjusted net revenue $330M-$340M, consensus $343.9M
- 05/10/22
- SoFi Technologies reports Q1 EPS (14c), consensus (14c)
- 05/10/22
- SoFi Technologies sees FY22 adjusted revenue $1.51B, Bloomberg says
- 04/27/22
- Sallie Mae sees FY22 core EPS $2.80-$3.00, consensus $2.95
- 04/27/22
- Sallie Mae reports Q1 core EPS 46c, consensus 82c
- 04/27/22
- Notable companies reporting after market close
- 01/26/22
- Sallie Mae reports Q4 core EPS $1.05, consensus 97c
- 03/03/22
- Siga Technologies reports Q 4EPS 98c versus 26c last year
- 05/10/22
- PMV Pharmaceuticals reports Q1 EPS (41c), consensus (40c)
- 03/01/22
- PMV Pharmaceuticals reports 2021 EPS ($1.28), consensus ($1.22)
- 04/27/22
- Navient raises FY22 EPS view to $3.20-$3.30 from $3.00-$3.15, consensus $3.03
- 04/26/22
- Navient reports Q1 adjusted EPS 90c, consensus 75c
- 04/26/22
- Notable companies reporting after market close
- 01/26/22
- Navient sees FY22 EPS $3.00-$3.15, consensus $3.12
- 05/26/22
- Marvell sees Q2 adjusted EPS 56c, +/- 3c per share, consensus 55c
- 05/26/22
- Marvell reports Q1 adjusted EPS 52c, consensus 51c
- 03/03/22
- Marvell sees Q1 adjusted EPS 51c +/- 3c, consensus 50c
- $38.54 /
-19.89 (-34.04%) - 02/28/22
- Mirati Therapeutics reports Q4 EPS ($3.72), consensus ($3.00)
- 02/28/22
- Mirati Therapeutics reports Q4 EPS ($3072), consensus ($3.00)
- 05/26/22
- Medtronic sees Q1 organic revenue down 4.5%-5.5%, consensus $8.14B
- 05/26/22
- Medtronic sees Q1 EPS $1.10-$1.14, consensus $1.40
- 05/26/22
- Medtronic sees FY23 EPS $5.53-$5.65, consensus $5.82
- 05/26/22
- Medtronic reports Q4 EPS $1.52, consensus $1.56
- 05/26/22
- Macy's raises FY22 EPS view to $4.53-$4.95 from $4.13-$4.52, consensus $4.34
- 05/26/22
- Macy's reports Q1 EPS $1.08, consensus 82c
- 05/25/22
- Notable companies reporting before tomorrow's open
- 05/26/22
- iQIYI reports Q1 EPS 3c, consensus (11c)
- 03/01/22
- iQIYI reports Q4 EPS (20c), consensus (32c)
IOVA Iovance Biotherapeutics - 05/05/22
- Iovance Biotherapeutics reports Q1 EPS (58c), consensus (64c)
- 05/27/22
- Hibbett backs FY23 EPS view $9.75-$10.50, consensus $9.74
- 05/27/22
- Hibbett reports Q1 EPS $2.89, consensus $3.08
- 03/04/22
- Hibbett sees FY23 EPS $9.75-$10.50, consensus $9.85
- 03/04/22
- Hibbett reports Q4 EPS $1.25, consensus $1.35
- 05/26/22
- Gap cuts FY22 revenue view to down low-mid single digits from low single digits
- 05/26/22
- Gap cuts FY22 EPS view to 30c-60c from $1.85-$2.05
- 05/26/22
- Gap reports Q1 EPS (44c), consensus (13c)
- 05/26/22
- Notable companies reporting after market close
- 05/26/22
- Farfetch reports Q1 EPS (24c), consensus (28c)
- 02/24/22
- Farfetch reports Q4 adjusted EPS (3c), consensus (3c)
DIDI Symbol changed to DIDIY - 12/29/21
- Didi reports Q2 net loss (RMB 24.3B) vs. (RMB 63M) last year
- 05/26/22
- Dell Technologies reports Q1 adjusted EPS $1.84, consensus $1.39
- 02/24/22
- Dell Technologies reports Q4 adjusted EPS $1.72, consensus $1.95
- 02/24/22
- Notable companies reporting after market close
- 05/26/22
- Costco reports Q3 EPS $3.04, consensus $3.03
- 03/03/22
- Costco reports Q2 EPS $2.92, consensus $2.74
- 03/03/22
- Notable companies reporting after market close
- 05/10/22
- Boot Barn sees Q1 EPS $1.14, consensus $1.11
- 05/10/22
- Boot Barn sees FY23 EPS $6.41, consensus $5.56
- 05/10/22
- Boot Barn reports Q4 EPS $1.47, consensus $1.32
- 01/27/22
- Boot Barn reports Q3 EPS $2.23 ex-items, consensus $2.22
- 05/27/22
- Big Lots reports Q1 EPS (39c), consensus 93c
- 03/03/22
- Big Lots sees Q1 adjusted EPS $1.10-$1.20, consensus $1.28
- 03/03/22
- Big Lots reports Q4 adjusted EPS $1.75, consensus $1.89
- 01/10/22
- Big Lots sees Q4 performance at 'upper end' of expectations
|